USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Biomedical Research Laboratori
Address:
7899 Mastin
Overland Park, KS 66204
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $81,749.00 2
SBIR Phase II $269,150.00 1

Award List:

SYNTHESIS OF IMAGABLE IODINATED ESTRADIOL - PHASE I

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$33,500.00
Agency:
HHS
Principal Investigator:
Richard J. Baranczuk
Abstract:
N/a

SYNTHESIS OF IMAGABLE IODINATED ESTRADIOL - PHASE I

Award Year / Program / Phase:
1984 / SBIR / Phase II
Award Amount:
$269,150.00
Agency:
HHS
Principal Investigator:
Richard J. Baranczuk
Abstract:
The high incidence of breast cancer in women makes this disease the leading cancer type in this population. the proper staging of this cancer and the determination of the presence or absence of estrogen receptors play major roles in determining the course of treatment. presently availablemethods for… More

ANTI-IDIOTYPIC MONOCLONAL ANTIBODY (AIMA) THERAPY HAS CURATIVE POTENTIAL FOR LOW-GRADE B-CELL LYMPHOMAS THROUGH IMMUNOLOGIC DOWN REGULATION OF THE MALIGNANT IDIOTYPIC CLONE AS WELL AS ANTIBODY-DEPENDENT CELL MEDIATED CYTOTOXICITY.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$48,249.00
Agency:
HHS
Principal Investigator:
Richard j. baranczuk , PRINCIPAL INVESTIGATOR
Abstract:
Anti-idiotypic monoclonal antibody (aima) therapy has curative potential for low-grade b-cell lymphomas through immunologic down regulation of the malignant idiotypic clone as well as antibody-dependent cell mediated cytotoxicity. production of aima is patient-specific and labor intensive requiring… More